FDA.reportPublic FDA data

berotralstat 108 MG Oral Pellet [Orladeyo]

RxCUI
2728878
RxNorm name
berotralstat 108 MG Oral Pellet [Orladeyo]
Display name
berotralstat 108 MG Oral Pellet [Orladeyo]
Full name
berotralstat 108 MG Oral Pellet [Orladeyo]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3527ece1-e7e0-40b1-b0c5-6baeb0deabeborladeyo 108 MG Oral Pellet [PSN] · berotralstat 108 MG Oral Pellet [Orladeyo] [SBD] · Orladeyo 108 MG Oral Pellet [SY]38These highlights do not include all the information needed to use ORLADEYO ® safely and effectively. See full prescribing information for ORLADEYO. ORLADEYO (berotralstat) capsules, for oral use ORLADEYO (berotralstat) oral pellets Initial U.S. Approval: 202020260213